Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

BACKGROUND: Conventional magnetic resonance imaging (MRI) has improved the diagnosis and monitoring of multiple sclerosis (MS). In clinical trials, MRI has been found to detect treatment effects with greater sensitivity than clinical measures; however, clinical and MRI outcomes tend to correlate poo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastianello, Stefano, Giugni, Elisabetta, Amato, Maria Pia, Tola, Maria-Rosalia, Trojano, Maria, Galletti, Stefano, Luccichenti, Giacomo, Quarantelli, Mario, Picconi, Orietta, Patti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214173/
https://www.ncbi.nlm.nih.gov/pubmed/21999142
http://dx.doi.org/10.1186/1471-2377-11-125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214173/
https://www.ncbi.nlm.nih.gov/pubmed/21999142
http://dx.doi.org/10.1186/1471-2377-11-125

Ejemplares similares